Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Ullman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Stroke (Hoboken, N.J.)|January 26, 2026
Hemorrhage Expansion Rates Before and After Minimally Invasive Surgery for Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE II/IIIWendy C Ziai, Shervin Badihian, Natalie Ullman, et al.
JAMA Neurology|July 25, 2022
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe DisabilityVishank A Shah, Richard E Thompson, Gayane Yenokyan, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Stroke (Hoboken, N.J.)|January 26, 2026
Hemorrhage Expansion Rates Before and After Minimally Invasive Surgery for Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE II/IIIWendy C Ziai, Shervin Badihian, Natalie Ullman, et al.
JAMA Neurology|July 25, 2022
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe DisabilityVishank A Shah, Richard E Thompson, Gayane Yenokyan, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Pageof 2